Concert Pharmaceuticals Inc (OQ:CNCE)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CNCE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 16/20 Mar 13/20 Tung Roger D Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -14,601  
Mar 16/20 Mar 13/20 Tung Roger D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,601 $3.79
Mar 13/20 Mar 12/20 Auchincloss Thomas G Direct Ownership Common Stock P - Open market or private purchase 1,500 $8.52
Feb 19/20 Feb 14/20 Munsie Jeffrey A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 42,430  
Feb 19/20 Feb 14/20 Munsie Jeffrey A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 28,216  
Feb 19/20 Feb 14/20 Tung Roger D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 151,600  
Feb 19/20 Feb 14/20 Tung Roger D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 101,100  
Feb 19/20 Feb 14/20 Stuart Nancy Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 68,215  
Feb 19/20 Feb 14/20 Stuart Nancy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 45,363  
Feb 19/20 Feb 14/20 Cassella James V Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 42,430  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CNCE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 16/20 Mar 13/20 Tung Roger D Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -14,601  
Mar 16/20 Mar 13/20 Tung Roger D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,601 $3.79
Mar 13/20 Mar 12/20 Auchincloss Thomas G Direct Ownership Common Stock P - Open market or private purchase 1,500 $8.52
Feb 19/20 Feb 14/20 Munsie Jeffrey A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 42,430  
Feb 19/20 Feb 14/20 Munsie Jeffrey A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 28,216  
Feb 19/20 Feb 14/20 Tung Roger D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 151,600  
Feb 19/20 Feb 14/20 Tung Roger D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 101,100  
Feb 19/20 Feb 14/20 Stuart Nancy Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 68,215  
Feb 19/20 Feb 14/20 Stuart Nancy Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 45,363  
Feb 19/20 Feb 14/20 Cassella James V Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 42,430  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CNCE

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)